Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Clinical trial NCT06842524 · RECRUITING

Trial details

NCT number: NCT06842524
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Polycystic Ovary Syndrome (PCOS)

Start date: 2025-04-16
Primary completion: 2026-09-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.